Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart DiseaseInsights from ENGAGE AF-TIMI 48

被引：1
|
作者：
Owens, Ryan E. [1 ]
Kabra, Rajesh [2 ]
Oliphant, Carrie S. [3 ]
机构：
[1] Univ Oklahoma, Coll Pharm, Dept Pharm Clin & Adm Sci, Oklahoma City, OK 73106 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med, Div Cardiol, Memphis, TN 38163 USA
[3] Univ Tennessee, Coll Pharm, Methodist Univ Hosp, Dept Clin Pharm, Memphis, TN USA
来源：
CLINICAL CARDIOLOGY | 2017年 / 40卷 / 08期
关键词：
Valvular heart disease; Arrhythmia; all; management; WARFARIN;
D O I：
10.1002/clc.22690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 50 条
  • [21] The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy
    Gupta, Deepak K.
    Giugliano, Robert P.
    Ruff, Christian T.
    Claggett, Brian
    Murphy, Sabina
    Antman, Elliott
    Mercuri, Michele F.
    Braunwald, Eugene
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2016, 29 (06) : 537 - 544
  • [22] Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial
    Semco, Robert S.
    Bergmark, Regan W.
    Murphy, Sabina A.
    Cange, Abby L.
    Unverdorben, Martin
    Chen, Cathy Z. L.
    Ruff, Christian T.
    Antman, Elliott M.
    Giugliano, Robert P.
    Bergmark, Brian A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (02):
  • [23] Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial
    Cavallari, Ilaria
    Ruff, Christian T.
    Nordio, Francesco
    Deenadayalu, Naveen
    Shi, Minggao
    Lanz, Hans
    Rutman, Howard
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 102 - 107
  • [24] Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
    Zimerman, Andre
    Braunwald, Eugene
    Steffel, Jan
    Van Mieghem, Nicolas M.
    Palazzolo, Michael G.
    Murphy, Sabina A.
    Chen, Cathy Zi Li
    Unverdorben, Martin
    Ruff, Christian T.
    Antman, Elliott M.
    Giugliano, Robert P.
    JAMA CARDIOLOGY, 2024, 9 (09) : 817 - 825
  • [25] Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis?
    Yasumasu, Tomiya
    CIRCULATION JOURNAL, 2016, 80 (09) : 2056 - 2056
  • [26] Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial
    Xu, Haiyan
    Ruff, Christian T.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Nordio, Francesco
    Patel, Indravadan
    Shi, Minggao
    Mercuri, Michele
    Antman, Elliott M.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [27] Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis? - Reply
    Yamashita, Takeshi
    CIRCULATION JOURNAL, 2016, 80 (09) : 2057 - 2057
  • [28] Systemic, Non-cerebral, Arterial Embolism in 21,105 Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Results from the ENGAGE AF-TIMI 48 Trial
    Geller, Bram J.
    Ruff, Christian T.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Hanyok, James J.
    Jin, Jianqing
    Mercuri, Michele
    Antman, Elliott M.
    CIRCULATION, 2014, 130
  • [29] A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial
    Fanola, Christina L.
    Giugliano, Robert P.
    Ruff, Christian T.
    Trevisan, Marco
    Nordio, Francesco
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    EUROPEAN HEART JOURNAL, 2017, 38 (12) : 888 - 896
  • [30] Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin - Insights From the ENGAGE AF-TIMI 48 Trial
    Shimada, Yuichi J.
    Yamashita, Takeshi
    Koretsune, Yukihiro
    Kimura, Tetsuya
    Abe, Kenji
    Sasaki, Shunichi
    Mercuri, Michele
    Ruff, Christian T.
    Giugliano, Robert P.
    CIRCULATION JOURNAL, 2015, 79 (12) : 2560 - +
12345